Navigation Links
New Lawsuit alleges Actos caused Bladder Cancer
Date:7/3/2012

San Diego, CA (PRWEB) July 03, 2012

The media spotlight is often a double-edged sword. No one knows this better than Ralph Penrod and people who suffer from Actos Side Effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on May 25th, 2012, Indiana man, Ralph Penrod, filed a lawsuit in Louisiana Western District Court (case no. 6:2012cv01340) alleging he suffered bladder cancer as a result of his use of the drug Actos. Actos, a popular medication used to control Type 2 diabetes manufactured by Takeda Pharmaceuticals, is allegedly linked to an increased risk of bladder cancer and other severe side effects. Plaintiff claims he was prescribed Actos in 2003 and took the medication until April 2011. He allegedly developed bladder cancer from Actos and underwent surgery in August 2011.

Penrod’s lawsuit is consolidated in the ongoing Actos Multi District Litigation (MDL 2299). On April 9th 2012, US District Judge Rebecca Doherty, overseeing the Actos Multidistrict Litigation signed a Direct Filing Order making it easier for individual plaintiffs to file lawsuit alleging injury caused by Actos.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Actos, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Actos remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In June 2011, the US FDA reported that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. In 2011, authorities in France and Germany banned sales of Actos.

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/6/prweb9650179.htm.

Read the full story at http://www.prweb.com/releases/2012/7/prweb9660766.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
2. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
3. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
4. New Lawsuit Alleges Teen Molestation by Ex-Deputy
5. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
6. New Lawsuit on Propecia: Severe Adverse Events
7. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
8. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
9. Researchers Offer Explanation for Actos Bladder Cancer Risk
10. Researchers Repair Damage Caused by Heart Attacks in Mice
11. Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... London, Ontario (PRWEB) , ... May 31, 2016 , ... ... more than 2,000 clients already know – London is home to Ontario’s leading day ... and direction of visionary Fayez Tamba began with a unique concept to combine spa ...
(Date:5/31/2016)... ... , ... In his latest video, renowned AstroNumerologist Jesse Kalsi ... presidential candidate Donald Trump as an example, Kalsi describes the way AstroNumerology conveys ... adding numbers up,” says Kalsi. “It is about looking at each individual number, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Interest is on ... screening tool and as an orthogonal tool for RNAi hit validation. A key reason ... specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. ...
(Date:5/31/2016)... ... ... In a recent interview on The Greenburgh Report radio show hosted by Greenburgh, NY ... AM), leading medical insurance advocate Adria Goldman Gross discussed several eye-opening issues that have ... During the interview with Mr. Feiner that aired on May 7, 2016, Ms. Gross, ...
(Date:5/31/2016)... Chicago, IL (PRWEB) , ... May 31, 2016 ... ... industry-leading multichannel marketing services firm and statement solutions provider, for the ... released in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)...   Plexus Technology Group, LLC (Plexus ... systems (AIMS), is pleased to announce the addition ... of Technology. In this new capacity, Mr. Marcey ... company,s technological development. He will collaborate with each ... expansion of new products, product features and enhancements.  ...
(Date:5/31/2016)... York , May 31, 2016 ... essential ingredient in food, cosmetics and pharmaceuticals, with global ... revenues worth US$ 1.6 Bn. Demand for ... products, juices, and yogurts will continue its upward momentum ... trend will also boost positive sentiment on aloe vera, ...
(Date:5/31/2016)... Israel , May 31, 2016 ... its proprietary plant-based rhCollagen technology for tissue repair products ... Chief Scientist of Israel,s Ministry ... 12 million development project for 2016. The Chief Scientist,s grant ... year,s authorized grant, which totaled NIS 4.7 million.  ...
Breaking Medicine Technology: